Breast cancer is the most diagnosed cancer in women globally, with approximately 70% of diagnoses being tumors that express estrogen receptors (ER+) but not human epidermal growth factor receptor 2 (HER2-)[1]. This evidence concerns the gene ERBB2 and cancer.